Concepedia

Author

Thomas Kuehr

Klinikum Wels-Grieskirchen

Also Known As

T Kuehr, T. Kuehr, Thomas Kuehr

16

Publications

265

Citations

8

H-Index

25

Concepts

All Affiliations

Klinikum Wels-GrieskirchenInnsbruck Medical UniversityUnfallkrankenhaus SalzburgKrankenhaus der Elisabethinen
TK

About

Thomas Kuehr is an author at Klinikum Wels-Grieskirchen specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

93

2

Immunology

2

2

65

3

Nephrology

1

1

28

4

Pathology

1

1

30

5

Pharmacology

1

1

28

Thomas Kuehr

×

6

Publications

234

Citations

6

H-Index

YearCitations

Adjuvant <i>nab</i> -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

Margaret A. Tempero, Uwe Pelzer, Eileen M. O’Reilly,

Journal of Clinical Oncology

2022

120

Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial

Kathleen M. Mullane, Vicki A. Morrison, Luis H. Camacho,

The Lancet Infectious Diseases

2019

35

Immunogenetic analysis of spontaneous autoimmune thyroiditis of obese strain chickens

Guido Kroemer, Nikolaus Neu, Thomas Kuehr,

Clinical Immunology and Immunopathology

1989

30

Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study

Heinz Ludwig, Elisabeth Rauch, Thomas Kuehr,

Haematologica

2014

28

A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha‐2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)—AGMT_CML 1

Sonja Heibl, Veronika Buxhofer‐Ausch, Stefan Schmidt,

Hematological Oncology

2020

11

Real-World Use and Effectiveness of Carfilzomib Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma in Europe

Evangelos Terpos, Renato Zambello, Xavier Leleu,

Cancers

2022

10

Page 1